Skip to main content

UNC to Create and Test Injectable Long-Acting Implant to Prevent HIV Infection

March 27, 2017

Researchers at the University of North Carolina at Chapel Hill have received a three-year, $1.8 million grant from the National Institutes of Health to develop a new implantable drug delivery system for long-lasting HIV-prevention. Scientists in the UNC School of Medicine’s Division of Infectious Diseases and the UNC Eshelman School of Pharmacy are developing an injectable drug delivery system that forms an implant that steadily releases anti-HIV medication over long periods of time. The injectable formulation includes an anti-HIV drug, a polymer and a solvent. The three-compound liquid will solidify once injected under the skin. As the polymer slowly degrades, … Read more


Postdoc Elizabeth Wayne Selected as TED Fellow

March 13, 2017

Elizabeth Wayne, Ph.D., a postdoctoral fellow in cancer nanotechnology at the UNC Eshelman School of Pharmacy, has been selected as a TED fellow and will take the stage to deliver a talk at TED2017 this April in Vancouver. She joins a class of 15 young innovators from four continents and a program that has selected 414 fellows from 87 countries since its inception in 2009. “As a graduate student, I wanted to use my physics training, but I wanted to solve a biological problem,” Wayne said. “The more I learned about cancer, the more I thought an interdisciplinary approach would … Read more


Ferreri Promoted to Clinical Professor

March 10, 2017

Stefanie Ferreri, Pharm.D., executive vice chair of the Division of Practice Advancement and Clinical Education, has been promoted to the rank of clinical professor. Ferreri joined the UNC Eshelman School of Pharmacy as a clinical assistant professor in 2001 and was promoted to clinical associate professor in 2009. She was named executive vice chair of PACE in 2012. Ferreri served as director of the School’s PGY1 Community Pharmacy Residency Program from 2004 to 2015 and currently directs the Community Pharmacy Research Fellowship and the Independent Pharmacy Ownership Residency. Her main research interests are advancing clinical practice and transforming practice models … Read more


Mosedale Receives Sternfels Prize for Proposal to Better Predict Liver-Injury Risk

March 9, 2017

Merrie Mosedale, Ph.D., a research assistant professor in the UNC Eshelman School of Pharmacy, has been awarded the $35,000 Sternfels Prize for Drug Safety Innovation for her proposal to find a molecular “fingerprint” to help identify people at risk for idiosyncratic, or unexplained, adverse drug reactions. Mosedale is a member of the UNC Institute for Drug Safety Sciences. The Sternfels Prize was created to encourage researchers to find ways to make using pharmaceuticals less risky. It is awarded to the most important and testable idea to reduce life-threatening drug-drug, drug-disease or pharmacogenomic interactions. Mosedale’s research focuses on drug-induced liver injury, … Read more


Reducing Irregular-Heartbeat Admissions Earns UNC Best Practices Award in Pharmacy

February 24, 2017

For the sixth year in a row, a multidisciplinary team at UNC Hospitals that includes UNC Eshelman School of Pharmacy faculty has been recognized by the American Society of Health-System Pharmacists with a National Best Practices Award for reducing hospital admissions for atrial fibrillation patients by nearly 30 percent. The UNC team was selected as one of six recipients in the country. The award-winning project is titled, “Optimizing the Management of Patients Presenting to the Emergency Department with Atrial Fibrillation: Pharmacists at the Center of a New Treatment Paradigm.” Atrial fibrillation, the most common form of abnormal heartbeat in adults, … Read more


Kristy Ainslie Receives Tenure in DPMP

February 22, 2017

Kristy Ainslie, Ph.D., an associate professor in the Division of Pharmacoengineering and Molecular Pharmaceutics at the UNC Eshelman School of Pharmacy, has been granted tenure. Ainslie joined the School in 2014. Prior to that, she spent almost five years as an assistant professor in the Ohio State University’s Division of Pharmaceutics and Pharmaceutical Chemistry. The research of the Ainslie lab is centered on immune-targeted therapies for the development of vaccines and treatment of autoimmune and infectious diseases. Ainslie is currently working on host cell-directed therapeutics for treatment of pathogenic infections, as well as the formulation of safer vaccines to prevent … Read more


Associate Professor, Former Vice Dean Publish Pharmacokinetics Textbook

February 3, 2017

Award-winning current and former faculty members of the UNC Eshelman School of Pharmacy recently published a textbook on the concepts of pharmacokinetics. Adam Persky, Ph.D., is a clinical associate professor in the Division of Pharmacotherapy and Experimental Therapeutics at the UNC Eshelman School of Pharmacy, and Gary Pollack, Ph.D., the first vice dean of the UNC Eshelman School of Pharmacy, is currently the dean of the College of Pharmacy at Washington State University. Both recipients of prestigious teaching awards, including Best Overall Instructor at the School, Persky and Pollack offer their perspectives on the concepts and important questions of pharmacokinetics … Read more


New Glioblastoma Treatment Successfully Tested with Human Cells

February 1, 2017

In a rapid-fire series of breakthroughs in just under a year, researchers at the UNC Eshelman School of Pharmacy have made another stunning advance in the development of an effective glioblastoma treatment for a common and aggressive brain cancer. The work, published in the Feb. 1 issue of Science Translational Medicine, describes how human stem cells, made from human skin cells, can hunt down and kill human brain cancer, a critical and monumental step toward clinical trials – and real treatment. Last year, the UNC-Chapel Hill team, led by Shawn Hingtgen, Ph.D., an assistant professor in the UNC Eshelman School … Read more


Bush Awarded 2017 AACP New Investigator Award

February 1, 2017

Antonio Bush, Ph.D., is the recipient of a 2017 American Association of Colleges of Pharmacy New Investigator Award, a grant of up to $10,000 that provides start-up funding to early-career pharmacy faculty for independent research programs. Recipients also receive a $1,000 travel award to present their research at the 2018 AACP Annual Meeting in Boston. Bush is an assistant professor of educational innovation and research in the Division of Practice and Clinical Education and an assistant director in the Office of Strategic Planning and Assessment at the UNC Eshelman School of Pharmacy. Bush, who was one of 16 recipients selected … Read more


Dusetzina Named to National Academies Report Committee

January 9, 2017

Stacie Dusetzina, Ph.D., has been confirmed as a committee member for the National Academies of Sciences, Engineering and Medicine report titled “Ensuring Patient Access to Affordable Drug Therapies.” The committee is charged by the National Academy of Medicine (formerly the Institute of Medicine) with issuing a report with recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments and encourage innovations that address significant needs in health care. “Drug pricing and access are complex issues affecting pharmaceutical manufacturers, payers and patients,” Dusetzina said. “These topics have been at the forefront of discussions about … Read more